Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Should States Be Barred From Hiring Plaintiffs Firms? Pennsylvania High Court Takes Up The Question In Risperdal Suit

Executive Summary

Janssen has won the ear of the Pennsylvania Supreme Court in its effort to get a plaintiffs firm disqualified from representing the state in Risperdal litigation

You may also be interested in...

Zyprexa Settlement With W. Virginia Shows States Can Benefit In Solo Suits

Lilly's $22.5 million settlement with West Virginia to resolve litigation over its Zyprexa marketing shows the benefit for states in pursuing suits against pharmaceutical manufacturers on their own

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts